Interferon-driven brain phenotype in a mouse model of RNaseT2 deficient leukoencephalopathy.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
11 11 2021
Historique:
received: 24 05 2020
accepted: 14 10 2021
entrez: 12 11 2021
pubmed: 13 11 2021
medline: 25 12 2021
Statut: epublish

Résumé

Infantile-onset RNaseT2 deficient leukoencephalopathy is characterised by cystic brain lesions, multifocal white matter alterations, cerebral atrophy, and severe psychomotor impairment. The phenotype is similar to congenital cytomegalovirus brain infection and overlaps with type I interferonopathies, suggesting a role for innate immunity in its pathophysiology. To date, pathophysiological studies have been hindered by the lack of mouse models recapitulating the neuroinflammatory encephalopathy found in patients. In this study, we generated Rnaset2

Identifiants

pubmed: 34764281
doi: 10.1038/s41467-021-26880-x
pii: 10.1038/s41467-021-26880-x
pmc: PMC8586222
doi:

Substances chimiques

Endoribonucleases EC 3.1.-

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

6530

Informations de copyright

© 2021. The Author(s).

Références

J Immunol. 2005 Oct 1;175(7):4392-9
pubmed: 16177080
J Immunol. 1998 Nov 1;161(9):5016-26
pubmed: 9794439
Neuropediatrics. 2016 Dec;47(6):355-360
pubmed: 27643693
Neurobiol Aging. 2008 Jun;29(6):891-901
pubmed: 17215062
Nat Med. 2018 Dec;24(12):1837-1844
pubmed: 30420755
Neurobiol Aging. 2012 Jan;33(1):196.e29-40
pubmed: 20619937
Immunity. 2014 Feb 20;40(2):199-212
pubmed: 24530055
Exp Hematol. 2016 Oct;44(10):947-63
pubmed: 27373493
Adv Exp Med Biol. 2012;942:269-86
pubmed: 22399427
Nat Immunol. 2005 Jan;6(1):49-56
pubmed: 15568025
Mol Neurobiol. 2017 Oct;54(8):6542-6555
pubmed: 27734334
J Exp Med. 2005 Sep 5;202(5):637-50
pubmed: 16129706
Pharmacol Ther. 1999 Feb;81(2):77-89
pubmed: 10190580
J Biol Chem. 2004 Feb 6;279(6):4894-902
pubmed: 14615479
RNA Biol. 2017 May 4;14(5):587-602
pubmed: 27362366
J Neuroimmunol. 1995 May;58(2):145-55
pubmed: 7759604
Nat Rev Immunol. 2016 Sep;16(9):566-80
pubmed: 27455396
Nat Immunol. 2009 Jan;10(1):109-15
pubmed: 19060901
Mol Neurodegener. 2020 May 29;15(1):30
pubmed: 32471464
Nat Genet. 2009 Jul;41(7):773-5
pubmed: 19525954
Neuropediatrics. 2000 Jun;31(3):155-8
pubmed: 10963105
Br J Pharmacol. 2016 Feb;173(4):716-28
pubmed: 25917268
Immunity. 2020 Jul 14;53(1):54-77
pubmed: 32668228
EMBO J. 2013 Sep 11;32(18):2454-62
pubmed: 23872947
Nat Genet. 2014 May;46(5):503-509
pubmed: 24686847
Nat Genet. 2006 Aug;38(8):917-20
pubmed: 16845398
Nat Commun. 2015 Jan 20;6:5853
pubmed: 25600358
Acta Neurol Scand. 1985 Jun;71(6):504-9
pubmed: 4024861
Cell. 2019 Nov 27;179(6):1264-1275.e13
pubmed: 31778653
Mol Cell Biol. 2011 Sep;31(18):3802-19
pubmed: 21791617
Autoimmunity. 2018 Nov;51(7):333-344
pubmed: 30422000
Trends Genet. 2013 Oct;29(10):569-74
pubmed: 23810203
J Exp Med. 2012 Jul 30;209(8):1419-26
pubmed: 22802351
Dis Model Mech. 2018 Jun 27;11(6):
pubmed: 29752287
J Neurosci. 1998 Aug 1;18(15):5804-16
pubmed: 9671668
Proc Natl Acad Sci U S A. 2011 Jan 18;108(3):1099-103
pubmed: 21199949
J Neurosci. 2006 Aug 2;26(31):8206-16
pubmed: 16885234
STAR Protoc. 2021 Feb 02;2(1):100318
pubmed: 33554149
J Alzheimers Dis. 2019;69(2):363-375
pubmed: 30958376
Magn Reson Med. 1986 Dec;3(6):823-33
pubmed: 3821461
J Immunol. 2015 Feb 15;194(4):1403-7
pubmed: 25601924
Int Immunol. 2003 Jan;15(1):119-25
pubmed: 12502732
Nat Biotechnol. 2018 Dec 03;:
pubmed: 30531897
Genetics. 2009 Aug;182(4):1335-44
pubmed: 19535546
Genome Res. 2014 Jan;24(1):125-31
pubmed: 24253447
Bio Protoc. 2013 Sep 20;3(18):
pubmed: 27376106
Bioinformatics. 2020 Apr 15;36(8):2628-2629
pubmed: 31882993
Brain Res. 1999 Jul 17;835(1):46-61
pubmed: 10448195
EMBO J. 2015 Jun 12;34(12):1612-29
pubmed: 25896511
Neurology. 2005 Apr 26;64(8):1411-6
pubmed: 15851732
Nature. 2006 Oct 19;443(7113):787-95
pubmed: 17051205
J Exp Med. 2016 Nov 14;213(12):2527-2538
pubmed: 27821552
F1000Res. 2018 Sep 26;7:
pubmed: 30345004
J Autoimmun. 2019 Jun;100:84-94
pubmed: 30872080
J Cell Mol Med. 2019 Mar;23(3):1771-1783
pubmed: 30549232
Methods. 2001 Dec;25(4):402-8
pubmed: 11846609
Nature. 2020 Jan;577(7790):399-404
pubmed: 31915375
Immunity. 2020 Apr 14;52(4):591-605.e6
pubmed: 32294405
Science. 1994 Jun 24;264(5167):1918-21
pubmed: 8009221
Mol Cell Biol. 2004 Aug;24(15):6719-27
pubmed: 15254239
Arthritis Rheumatol. 2015 Jun;67(6):1592-7
pubmed: 25777993
J Immunol. 2016 Apr 15;196(8):3318-30
pubmed: 26962232
Eur J Paediatr Neurol. 2016 Jul;20(4):604-10
pubmed: 27091087
Immunol Rev. 2012 Sep;249(1):158-75
pubmed: 22889221
PLoS One. 2015 Jun 26;10(6):e0131702
pubmed: 26114879
Cogn Process. 2012 May;13(2):93-110
pubmed: 22160349
Appl Immunohistochem Mol Morphol. 2003 Mar;11(1):85-91
pubmed: 12610362
Nat Commun. 2017 Dec 19;8(1):2176
pubmed: 29259162
Glia. 2020 Jul;68(7):1531-1545
pubmed: 32212285
J Biol Chem. 2018 Dec 21;293(51):19633-19644
pubmed: 30385512
J Neuroinflammation. 2020 Nov 12;17(1):340
pubmed: 33183319

Auteurs

Matthias Kettwig (M)

Department of Pediatrics and Adolescent Medicine, Division of Pediatric Neurology, University Medical Center Göttingen, Georg August University, Göttingen, Germany. matthias.kettwig@med.uni-goettingen.de.

Katharina Ternka (K)

Department of Pediatrics and Adolescent Medicine, Division of Pediatric Neurology, University Medical Center Göttingen, Georg August University, Göttingen, Germany.

Kristin Wendland (K)

Department of Pediatrics and Adolescent Medicine, Division of Pediatric Neurology, University Medical Center Göttingen, Georg August University, Göttingen, Germany.

Dennis Manfred Krüger (DM)

Department for Epigenetics and Systems Medicine in Neurodegenerative Diseases, German Center for Neurodegenerative Diseases (DZNE), Göttingen, Germany.

Silvia Zampar (S)

Department of Psychiatry and Psychotherapy, University Medical Center Göttingen, Georg August University, Göttingen, Germany.

Charlotte Schob (C)

Department of Pediatrics and Adolescent Medicine, Division of Pediatric Neurology, University Medical Center Göttingen, Georg August University, Göttingen, Germany.

Jonas Franz (J)

Institute of Neuropathology, University Medical Center Göttingen, Georg August University, Göttingen, Germany.
Campus Institute for Dynamics of Biological Networks, University of Göttingen, Göttingen, Germany.
Max Planck Institute for Experimental Medicine, Göttingen, Germany.

Abhishek Aich (A)

Department of Cellular Biochemistry, University Medical Center Göttingen, Georg August University, Göttingen, Germany.

Anne Winkler (A)

Institute of Neuropathology, University Medical Center Göttingen, Georg August University, Göttingen, Germany.

M Sadman Sakib (MS)

Department for Epigenetics and Systems Medicine in Neurodegenerative Diseases, German Center for Neurodegenerative Diseases (DZNE), Göttingen, Germany.

Lalit Kaurani (L)

Department for Epigenetics and Systems Medicine in Neurodegenerative Diseases, German Center for Neurodegenerative Diseases (DZNE), Göttingen, Germany.

Robert Epple (R)

Department for Epigenetics and Systems Medicine in Neurodegenerative Diseases, German Center for Neurodegenerative Diseases (DZNE), Göttingen, Germany.

Hauke B Werner (HB)

Department of Neurogenetics, Max Planck Institute of Experimental Medicine, Göttingen, Germany.

Samy Hakroush (S)

Institute of Pathology, University Medical Center Göttingen, Georg August University, Göttingen, Germany.

Julia Kitz (J)

Institute of Pathology, University Medical Center Göttingen, Georg August University, Göttingen, Germany.

Marco Prinz (M)

Institute of Neuropathology, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Signalling Research Centres BIOSS and CIBSS, University of Freiburg, Freiburg, Germany.
Center for Basics in NeuroModulation (NeuroModulBasics), Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Eva Bartok (E)

Institute of Clinical Chemistry and Clinical Pharmacology, University Hospital, University of Bonn, Bonn, Germany.
Unit of Experimental Immunology, Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.

Gunther Hartmann (G)

Institute of Clinical Chemistry and Clinical Pharmacology, University Hospital, University of Bonn, Bonn, Germany.

Simone Schröder (S)

Department of Pediatrics and Adolescent Medicine, Division of Pediatric Neurology, University Medical Center Göttingen, Georg August University, Göttingen, Germany.

Peter Rehling (P)

Department of Cellular Biochemistry, University Medical Center Göttingen, Georg August University, Göttingen, Germany.

Marco Henneke (M)

Department of Pediatrics and Adolescent Medicine, Division of Pediatric Neurology, University Medical Center Göttingen, Georg August University, Göttingen, Germany.

Susann Boretius (S)

Functional Imaging Laboratory, German Primate Center, Leibniz Institute for Primate Research, Göttingen, Germany.

A Alia (A)

Institute for Medical Physics and Biophysics, University of Leipzig, Leipzig, Germany.
Leiden Institute of Chemistry, Leiden University, Leiden, The Netherlands.

Oliver Wirths (O)

Department of Psychiatry and Psychotherapy, University Medical Center Göttingen, Georg August University, Göttingen, Germany.

Andre Fischer (A)

Department for Epigenetics and Systems Medicine in Neurodegenerative Diseases, German Center for Neurodegenerative Diseases (DZNE), Göttingen, Germany.
Department of Psychiatry and Psychotherapy, University Medical Center Göttingen, Georg August University, Göttingen, Germany.

Christine Stadelmann (C)

Institute of Neuropathology, University Medical Center Göttingen, Georg August University, Göttingen, Germany.

Stefan Nessler (S)

Institute of Neuropathology, University Medical Center Göttingen, Georg August University, Göttingen, Germany.

Jutta Gärtner (J)

Department of Pediatrics and Adolescent Medicine, Division of Pediatric Neurology, University Medical Center Göttingen, Georg August University, Göttingen, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH